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ABSTRACT 
Bromelain, an enzyme from the pineapple plant has varied pharmacological activities, out of 
which it shows specific anticancer activity and now is gaining attention regarding this 
aspect. Medicinal qualities of bromelain include antiedematous; anti-inflammatory, anti-
thrombotic, fibrinolytic, immunogenicity and it is used in the treatment of thrombosis and 
thrombophlebitis, diarrhea, debridement of burns etc. This article reviews the mechanism 
and efficacy of bromelain in fighting against tumor cells, inspite of it being a natural drug 
with enzymatic background. Bromelain shows antimetastatic efficacy and inhibits platelet 
aggregation, growth, and invasiveness of tumor cells. Its effectiveness and safety in cancer 
treatment has to be considered due to its Selective cytotoxicity. Bromelain being a plant 
extract, contains various components such as proteinases, peroxidises, phosphatises, 
protease inhibitors and organically bound calcium. These components might contribute to 
the variations of bromelain’s pharmacological activities. The main aim of this article is to 
focus the safety and efficacy of this drug in cancer treatment and comparing it with other 
chemotherapeutic agents. 
KEYWORDS: Apoptosis, Anti-angiogenetic activity, Bromelain, Metastasis, Proteolytic 
Enzymes, Safety. 
INTRODUCTION
Pineapple is the common name of Ananas 
comosus (syn. A. sativus, Ananassa sativa, Bromelia 
ananas, B. comosa). Pineapple is the leading edible 
member of the family Bromeliaceae, grown in 
several tropical and subtropical countries 
including Philippines, Thailand, Indonesia, 
Malaysia, Kenya, India, and China. It has been used 
as a medicinal plant in several native cultures 
Bromelain is a crude extract from 
pineapple & has been chemically known since 
1875 and is used as a phytomedical compound. It 
is an enzyme that undergoes breakdown of 
proteins. It is a mixture of substances, mainly 
composed of two sulfhydril-containing protein-
digesting enzymes called proteolytic enzymes or 
proteases. Bromelain also contains peroxidase, 
acid phosphatase, several protease inhibitors and 
organically bound calcium and remains stable 
over a wide range of pH 2 to 9. Available evidence 
indicates that bromelain is well absorbed orally 
with its therapeutic effects being enhanced in a 
dose dependent manner. 
ANTIMETASTATIC MECHANISM 
Existing evidence derived from clinical 
observations as well as from mouse- and cell-
based models suggests that bromelain acts 
systemically, affecting multiple cellular and 
molecular targets. Bromelain shows 
antimetastatic efficacy and inhibits platelet 
aggregation, growth, and invasiveness of tumor 
cells. In recent years, studies have shown that 
bromelain has the capacity to modulate key 
pathways that support malignancy. It is now 
possible to suggest that the anti-cancer activity of 
bromelain consists in the direct impact on cancer 
cells and their micro-environment, as well as in 
the modulation of immune, inflammatory and 
haemostatic systems.[1] 
Bromelain is an enzyme and this 
background can be used for anticancer activity. 
Proteolytic enzymes can be helpful in treating 
cancer as they help restore balance to your 
immune system. 
Some of the ways proteolytic enzymes can 
be helpful in the fight against cancer are by 
boosting cytokines, particularly interferon and 
tumor necrosis factor, which are very important 
warriors in destroying cancer cells. Another way 
by decreasing inflammation is by dissolving fibrin 
as Cancer cells hide under a cloak of fibrin to 
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escape detection. Once the cancer cells are 
"uncloaked," they can be spotted and attacked by 
your immune system. It is also thought that fibrin 
makes cancer cells "stick together," which 
increases the chance for metastases. German 
studies have shown that systemic enzymes 
increase the potency of macrophages and killer 
cells 12-fold.[2] Researchers have now identified 
several cancer-killing mechanisms of bromelain, 
including deactivation of the key gene signal NF-
kappaB and induction of the autophagy process 
that causes the cancer cell to self destruct. 
Another recent study in human breast cancer cells 
showed that bromelain could activate the process 
of autophagy in cancer cells, causing them to “eat 
themselves” and die.[3] Autophagy is a normal 
house cleaning process in healthy cells. In cancer 
cells the process is hijacked. The fact that 
bromelain can turn the tables on cancer cells is 
quite interesting.[4] Recent studies have shown 
that bromelain has the capacity to modify key 
pathways that support malignancy.  
Presumably, the anticancerous activity of 
bromelain is due to its direct impact on cancer 
cells and their microenvironment, as well as on 
the modulation of immune, inflammatory, and 
haemostatic systems.[1] Most of the in vitro and in 
vivo studies on anticancer activity of bromelain 
are concentrated on mouse and human cells, both 
cancerous and normal, treated with bromelain 
preparations.  
In an experiment conducted by Beez et al 
chemically induced mouse skin papillomas were 
treated with bromelain and they observed that it 
reduced tumor formation, tumor volume and 
caused apoptotic cell death.[5] 
 In one study related to bromelain 
treatment of gastric carcinoma Kato III cell lines, 
significant reduction of cell growth was 
observed[6] while in another study bromelain 
reduced the invasive capacity of glioblastoma cells 
and reduce novoprotein synthesis.[7] Bromelain is 
found to increase the expression of p53 and Bax in 
mouse skin, the well-known activators of 
apoptosis.[1] Bromelain also decreases the activity 
of cell survival regulators such as Akt and Erk, 
thus promoting apoptotic cell death in tumours. 
Different studies have demonstrated the role of 
NF-κB, Cox-2, and PGE2 as promoters of cancer 
progression.  
Evidence shows that the signaling and 
over expression of NF-κB plays an important part 
in many types of cancers.[8,9] 
Cox-2, a multiple target gene of NF-κB, 
facilitates the conversion of arachidonic acid into 
PGE2 and thus promotes tumour 
angiogenesis.[10,11] 
It is considered that inhibiting NF-κB, Cox-
2, and PGE2 activity has potential as a treatment 
of cancer. Bromelain was found to down regulate 
NF-κB and Cox-2 expression in mouse papillomas 
and in models of skin tumourigenesis.[12] 
Bromelain was also shown to inhibit bacterial 
endotoxin (LPS)-induced NF-κB activity as well as 
the expression of PGE2 and Cox-2 in human 
monocytic leukemia and murine microglial cell 
lines. [13] 
Bromelain markedly has in 
vivo antitumoural activity for the following cell 
lines: P-388 leukemia, sarcoma (S-37), Ehrlich 
ascetic tumour, Lewis lung carcinoma, and ADC-
755 mammary adenocarcinoma. In these studies, 
intraperitoneal administration of bromelain after 
24 hours of tumour cell inoculation resulted in 
tumour regression.[5] 
Bromelain with similar regulating actions 
has shown protective properties on tumour cell 
growth retardation & Lung metastasis.[6] Batkin, 
while studying the antimetastatic effect of 
Bromelain with or without its proteolytic & 
anticoagulant activities in animal model of Lewis 
Lung Carcinoma, reported significant reduction in 
total number of metastasis in both active and 
inactive forms of bromelain as compared to 
control groups. A study result reported by 
researchers of Queensland Institute of Medical 
Research (QIMR) reports discovery of two new 
proteins CCS & CCZ which were found to block 
growth of broad range of tumour cells in breast, 
lung, colon, ovarian and melanoma. Although 
more studies are to be done on them.[18] 
SAFETY IN CANCER CHEMOTHERAPY 
Chemotherapy drugs are, by their very 
nature, extremely toxic and typically work against 
your body's natural ability to fight cancer, e.g. 
destroying host immunity instead of supporting 
it. One of the biggest drawbacks to chemotherapy 
is the fact that it destroys healthy cells throughout 
your body right along with cancer cells, a "side 
effect" that often leads to accelerated death, not 
healing. Another devastating side effect of 
chemotherapy is the way it actually supports the 
more chemo resistant and malignant cell 
subpopulations within tumors (e.g. cancer stem 
cells), both killing the more benign cells and/or 
senescent cells within the tumor that keep it slow-
growing, or even harmless. A handful of natural 
compounds have been discovered, however, 
which exhibit an effect called "selective 
cytotoxicity." This means they are able to kill 
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cancer cells while leaving healthy cells and tissue 
unharmed. This type of cancer treatment is 
intelligent, targeted and will not result in the 
death of the patient from "collateral damage" in 
what is increasingly a failed war not against the 
cancer being treated, but the patient's own 
irreversibly devastated body. One such compound 
is bromelain, an enzyme that can be extracted 
from pineapple stems. Research published in the 
journal Planta Medica found that bromelain was 
superior to the chemotherapy drug 5-
fluorauracil in treating cancer in an animal 
study. Researchers stated that the antitumoral 
effect of bromelain was superior to that of 5-FU 
[5-fluorouracil], whose survival index was 
approximately 263 %, relative to the untreated 
control.[15,17] 
Bromelain worked without causing 
additional harm to the animals. The chemo drug 5-
fluorauracil, on the other hand, has a relatively 
unsuccessful and dangerous track record despite 
being used for nearly 40 years. As written by 
Green Med Info: "As a highly toxic, fluoride-bound 
form of the nucleic acid uracil, a normal 
component of RNA, the drug is supposed to work 
by tricking more rapidly dividing cells, which 
include both cancer and healthy intestinal, hair 
follicle, and immune cells, into taking it up, 
thereby inhibiting RNA replication enzymes and 
RNA synthesis[16]. Selective cytotoxicity is indeed a 
property that is only found among natural 
compounds; no chemotherapy drug yet developed 
is capable of this effect. This proves safety and 
lesser side effects of bromelain, a boon from 
nature. 
CONCLUSION 
Bromelain can be a promising natural 
supplement for the development of oral enzyme 
therapies for oncology patients. Bromelain is a 
multiaction enzyme. However its safety and 
efficacy as anticancer agent is appreciable and 
research should be progressed in the view. 
Abundant source & easy availability of bromelain 
from pineapple are added advantages for its use in 
various treatments, Cancer being the prominent 
one. 
The science now supports the use of 
bromelain as part of a natural support strategy for 
any cancer treatment or for prevention. As more 
research is done the precise mechanisms of 
bromelain in the war on cancer will be better 
understood. The data to this point indicates that 
bromelain is yet another nutrient, like green tea, 
curcumin, quercetin, resveratrol, and tocotrienols, 
that are able to tell the difference between cancer 
cells and healthy cells, helping to kill the former 
while assisting the survival of the healthy cells. 
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